Back to top
more

ABIOMED, Inc. (ABMD)

(Delayed Data from NSDQ)

$271.75 USD

271.75
1,074,902

+6.98 (2.64%)

Updated May 3, 2019 04:00 PM ET

After-Market: $271.72 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ABMD]

Reports for Purchase

Showing records 201 - 220 ( 286 total )

Industry: Medical - Instruments

Record: 201

03/05/2012

Company Report

Pages: 4

AMA announces a Category I code for percutaneous assist devices?

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 202

03/05/2012

Daily Note

Pages: 3

AMA announces a Category I code for percutaneous assist devices

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 203

02/07/2012

Daily Note

Pages: 3

Waiting for CPT code for percutaneous assist devices

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 204

02/07/2012

Company Report

Pages: 4

Waiting for CPT code for percutaneous assist devices

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 205

02/07/2012

Daily Note

Pages: 4

Stock Hit on Outdated Reimbursement Concerns; Fears Do Not Appear Justified; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 206

02/07/2012

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Instruments

Record: 207

02/03/2012

Company Report

Pages: 7

Best Impella Revenues to Date; Expect Sustained Profitability; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 208

01/31/2012

Company Report

Pages: 5

FQ3:2012 Preview; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 209

12/20/2011

Daily Note

Pages: 3

Downgrading to Underperform...Breathtaking spin on PROTECT-II continues....

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 210

12/20/2011

Company Report

Pages: 18

Downgrading to Underperform...Breathtaking spin on PROTECT-II continues...

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 211

12/19/2011

Daily Note

Pages: 3

Downgrading to Underperform-Breathtaking spin on PROTECT-II continues.....

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 212

12/19/2011

Company Report

Pages: 18

Downgrading to Underperform-Breathtaking spin on PROTECT-II continues.....

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 213

12/18/2011

Company Report

Pages: 18

Downgrading to Underperform-Breathtaking spin on PROTECT-II continues

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 214

12/18/2011

Daily Note

Pages: 3

Downgrading to Underperform-Breathtaking spin on PROTECT-II continues

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 215

12/12/2011

Company Report

Pages: 6

Analyst Day Provides Encouraging Pipeline Updates

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 216

11/10/2011

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Instruments

Record: 217

11/04/2011

Daily Note

Pages: 12

MORNING SUMMARY

Provider: RODMAN & RENSHAW, CO.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 218

11/03/2011

Daily Note

Pages: 3

Company continues strong salesUtilization rates do not indicate strong trend though

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 219

11/03/2011

Company Report

Pages: 7

Company continues strong sales Utilization rates do not indicate strong trend though

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 220

11/03/2011

Company Report

Pages: 6

Profitable FQ2:11 on Impressive Impella Revenues

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 25.00

Research Provided by a Third Party
// eof